Study of Antiviral Efficiency of Oxidized Dextrans In Vitro and In Vivo


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Antiviral efficiency of oxidized dextrans (OD) with different molecular weights and oxidation degree (OD40min, OD70min, OD40max, and OD70 max) was studied in vitro and in vivo. Dextrans OD40max and OD70max prevented the development of the cytopathic effect of influenza A(H1N1)pdm09 virus in more than 50% MDCK cells vs. control (no OD). Four intranasal doses of OD40min, OD40max, and OD70min and one intranasal dose of OD70max before infection of BALB/c mice with A(H1N1)pdm09 influenza virus significantly reduced mortality and prolonged life span in comparison with controls receiving saline. These and our previous data attest to clear-cut preventive effect of OD in influenza infection.

Sobre autores

O. Kurskaya

Research Institute of Experimental and Clinical Medicine

Autor responsável pela correspondência
Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

T. Murashkina

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

A. Alekseev

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

K. Sharshov

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

L. Romakh

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

A. Derko

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

A. Troitskii

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

T. Bystrova

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk

V. Shkurupy

Research Institute of Experimental and Clinical Medicine; Novosibirsk Medical University, Ministry of Health of the Russian Federation

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk; Novosibirsk

A. Shestopalov

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Rússia, Novosibirsk


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies